Adding chemotherapy to hormone therapy added 14 months to patients’ lives in study

Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds. Over nearly 29 months of follow-up, men with advanced prostate cancer who received the combination therapy lived almost 14 months longer than men who received only hormone therapy (58 months versus 44 months), researchers said. Read the article.

Pomegranate Extract Not Helpful

A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. This article found no significant effect. Read the article.

Latest Dietary Advice for Prostate Cancer

A new BMC Medicine review details a variety of foods, nutrients, and diets that may hold promise for reducing the incidence or progression of prostate cancer (PCa). Not a lot new in this article, but a lot of detail in the actual medical journal article available with a click. Read the article.

Scroll to Top